Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2261011827
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, B. K.
Right arrow Articles by Lee, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, B. K.
Right arrow Articles by Lee, S. J.
(Radiology 2003;226:79-85.)
© RSNA, 2003


Gastrointestinal Imaging

Preoperative Depiction of Hepatocellular Carcinoma: Ferumoxides-enhanced MR Imaging versus Triple-Phase Helical CT1

Bo Kiung Kang, MD, Jae Hoon Lim, MD, Seung Hoon Kim, MD, Dongil Choi, MD, Hyo Keun Lim, MD, Won Jae Lee, MD and Soon Jin Lee, MD

1 From the Department of Radiology and Center for Imaging Science, Sungkyunkwan University School of Medicine, 50 Ilwon-Dong, Kangnam-Ku, Seoul 135-710, Korea. Received November 14, 2001; revision requested January 24, 2002; revision received March 5; accepted April 16. Address correspondence to J.H.L. (e-mail: jhlim@smc.samsung.co.kr).

PURPOSE: To compare ferumoxides-enhanced magnetic resonance (MR) imaging with triple-phase helical computed tomography (CT) for the preoperative depiction of hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: Seventy consecutive patients with a total of 79 HCC nodules underwent ferumoxides-enhanced MR imaging and triple-phase helical CT before surgery. The diagnosis of HCC was established by means of pathologic examination after surgical resection in all patients. MR images obtained with all sequences and triple-phase helical CT images were reviewed independently by three radiologists on a segment-by-segment basis. Accuracy for diagnosis of HCC was assessed by applying receiver operating characteristic (ROC) analysis to observations of 78 hepatic segments with at least one HCC nodule and 70 segments without HCC.

RESULTS: The diagnostic accuracy of findings at ferumoxides-enhanced MR imaging (with mean area-under-the-ROC-curve [Az] values for the three observers of 0.986, 0.979, and 0.980) was significantly higher (P < .001) than that of findings at triple-phase helical CT (with mean Az values for the three observers of 0.945, 0.948, and 0.964). The mean sensitivity of MR imaging (95%, 222 of 234 segments) was also significantly higher than that of triple-phase helical CT (88%, 205 of 234 segments) (P = .001, McNemar test). The mean specificity was 97% (261 of 270 segments) for MR imaging and 98% (264 of 270 segments) for CT, but this difference was not significant (P = .754, McNemar test).

CONCLUSION: Ferumoxides-enhanced MR imaging is superior to triple-phase helical CT for the preoperative depiction of HCC.

© RSNA, 2003

Index terms: Computed tomography (CT), phase imaging, 761.12114 • Iron • Liver neoplasms, CT, 761.12114 • Liver neoplasms, MR, 761.12143 • Magnetic resonance (MR), contrast media, 761.12143 • Receiver operating characteristic (ROC) curve




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
S. H. Kim, S. H. Kim, J. Lee, M. J. Kim, Y. H. Jeon, Y. Park, D. Choi, W. J. Lee, and H. K. Lim
Gadoxetic Acid-Enhanced MRI Versus Triple-Phase MDCT for the Preoperative Detection of Hepatocellular Carcinoma
Am. J. Roentgenol., June 1, 2009; 192(6): 1675 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. J. Kim, J. M. Lee, J. K. Han, K. H. Kim, J. Y. Lee, and B. I. Choi
Peripheral Mass Forming Cholangiocarcinoma in Cirrhotic Liver
Am. J. Roentgenol., December 1, 2007; 189(6): 1428 - 1434.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. K. Kim, H. S. Kwak, C. S. Kim, G. H. Chung, Y. M. Han, and J. M. Lee
Hepatocellular Carcinoma in Patients with Chronic Liver Disease: Comparison of SPIO-enhanced MR Imaging and 16-Detector Row CT
Radiology, December 21, 2005; (2005) 2381042193.
[Abstract] [Full Text]


Home page
RadiologyHome page
A. M. Lutz, J. K. Willmann, K. Goepfert, B. Marincek, and D. Weishaupt
Hepatocellular Carcinoma in Cirrhosis: Enhancement Patterns at Dynamic Gadolinium- and Superparamagnetic Iron Oxide-enhanced T1-weighted MR Imaging
Radiology, November 1, 2005; 237(2): 520 - 528.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. H. Kim, D. Choi, S. H. Kim, J. H. Lim, W. J. Lee, M. J. Kim, H. K. Lim, and S. J. Lee
Ferucarbotran-Enhanced MRI Versus Triple-Phase MDCT for the Preoperative Detection of Hepatocellular Carcinoma
Am. J. Roentgenol., April 1, 2005; 184(4): 1069 - 1076.
[Abstract] [Full Text] [PDF]